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Abstract (word limit: 150, word count: 148) 
 
Dietary restriction (DR), a moderate reduction in food intake, improves health 
during ageing and extends lifespan across multiple species. Specific nutrients, 
rather than overall calories, mediate the effects of DR, with protein and 
specific amino acids playing a key role. Modulations of single dietary amino 
acids affect traits including growth, reproduction, physiology, health, and 
longevity in animals. Epidemiological data in humans also link the quality and 
quantity of dietary proteins to long term health. Intricate nutrient-sensing 
pathways fine-tune the metabolic responses to dietary amino acids in a highly 
conserved manner. In turn, these metabolic responses can affect the onset of 
insulin resistance, obesity, neurodegenerative disease, and other age-related 
diseases. In this review we discuss how amino acid requirements are shaped, 
how ingested amino acids regulate a spectrum of homeostatic processes, and 
finally we highlight the unique opportunity of using related nutritional 
strategies to improve human health during ageing. 
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(WORD COUNT: 9,117) 
 
1. Introduction 
 
I. Diet and health 
Obesity and its associated metabolic diseases are a global health problem, 
linked to reduced life expectancy. Both quantity and quality of food intake are 
clearly important in the development of obesity, with excess fat (1) and 
carbohydrate intake detrimental to health and lifespan in flies (2), mice (3), 
and humans (4). Clearly diets that promote obesity should be avoided, as 
should those that induce nutritional deficiencies. But what dietary 
compositions best promote health, and why? Does the optimal balance of 
macronutrients vary with age, gender, genotype or disease state? Defining 
the macronutrient composition of a healthy diet, and identifying the molecular 
and physiological mechanisms by which it promotes health, are important 
challenges. In this review, we focus particularly on the roles of dietary protein. 
 
II. Dietary restriction 
A nutritional intervention that has clear health benefits is dietary restriction 
(DR), a moderate reduction in food intake that protects against multiple 
ageing-related diseases and impairments, and extends lifespan in most 
animals tested. The severity of DR can range from ~10 to ~50% of ad libitum 
intake levels, and the lifespan increase can be as modest as a few percent or 
as high as three-fold (5) . In rodents and primates, DR protects against 
ageing-related loss of function and disease, including cardiovascular disease, 
obesity, multiple cancers, neurodegeneration, nephropathy, loss of sensory, 
motor and immune function, and diabetes (5-6) . Short-term DR in humans 
also benefits glucose and energy homeostasis, increasing insulin sensitivity 
and reducing body fat (5) . However, DR is not a practical intervention for 
most humans because it is difficult to implement and sustain. Moreover, DR 
can decrease wound healing capacity and increase susceptibility to viral 
infections (5). Thus an important aim is to identify the nutrients that mediate 
the health benefits of DR. Understanding the physiological and molecular 
mechanisms by which these key nutrients exert their effects may pave the 
way to DR-mimicking diets, as well as pharmacological interventions to 
improve health during ageing with minimal side-effects.   
 
III. Dietary protein and amino acids 
Recent findings have increasingly pointed to a causal role of the protein 
component of the diet in promoting the health and lifespan benefits of DR. In 
the fruit fly Drosophila, restriction of dietary yeast, the fly’s usual protein 
source, but much less so of carbohydrate or total calories, extends lifespan 
(7), an effect attributable to the amino acids (AAs) (8) and the protein-to-
carbohydrate ratio of the diet (2). In mice (3) and rats (9), reducing dietary 
protein, thereby decreasing the diet’s protein-to-carbohydrate ratio, also 
increases healthspan and lifespan. The beneficial effects of protein restriction 
outweigh those of carbohydrate or fat restriction (3,10-11). Indeed, dietary 
carbohydrates and fats are largely interchangeable without detrimental effects 
in many species (1,12). Moreover, specific AAs or their ratio can determine 
health and ageing, because reduced intake of methionine in Drosophila (8), 
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and of methionine or tryptophan in rodents (13-14) results in improved health 
during ageing and increased lifespan. Additionally, increases in circulating 
branched-chain AAs (BCAAs) stimulate the target of rapamycin (TOR) and 
IGF/insulin signaling (IIS) pathways in rodents (3, 15), which may be 
detrimental for health, since suppression of TOR and IIS signaling is often 
beneficial for a healthy lifespan (5). The mechanisms by which individual 
dietary amino acids affect metabolism and health are starting to be 
understood, and are revealing potential targets for improvement of organismal 
health during ageing.  
 
2. Dietary restriction, health, and ageing 
 
I. Protective effects of dietary restriction  
The physiological, metabolic, and molecular changes through which DR 
extends healthspan and lifespan are becoming clearer, although a complete 
account is lacking for any organism. Reduction in nutrient intake triggers 
modulations in the activity of nutrient-sensing pathways, which stimulate 
protective mechanisms over most aspects of health during ageing. From flies 
to humans, the DR response is highly conserved and involves an extensive 
array of protective metabolic changes that include an increase in stress 
resistance, detoxification capacity, and genome stability, and promotion of 
proteostasis and energy homeostasis (5,106). The IIS and TOR pathways are 
also conserved in humans, and so are their responses to DR (5). Long-term 
and short-term DR trials in humans result in marked reductions in IIS and 
TOR signaling, decreasing multiple risk factors such as obesity, insulin 
resistance, and cardiovascular disease (16). These evolutionarily conserved 
responses to DR present an opportunity for significant health-promoting 
applications in human nutrition (11). Apart from its effects on energy 
homeostasis, DR also reduces cancer propensity. A reduction in tumour 
incidence (lymphomas, pituitary, and thyroid neoplasms) accompanies DR 
treatment in mice (6). Furthermore, primate studies also implicate dietary 
protein in health during ageing. Two recent Rhesus monkey lifespan trials 
found conflicting results, with one (WNPRC), but not the other (NIA), reporting 
a lifespan extension as a response to DR (11), although both found multiple 
improvements in health in the DR animals. Among several experimental 
differences between the two trials, differences in the amount and type of 
dietary protein were prominent (5,11). In humans too, DR reduces IGF-I and 
decreases the risk of cancer (16). However, DR in humans only lowers 
circulating IGF-I if protein intake is also restricted (5). Human trials also 
highlight a role for protein quality, because diets containing low, plant-based 
AAs promote multiple aspects of healthspan (17). Such findings emphasize a 
difference between protein sources, for example plant versus animal protein, 
discussed further below. Moreover, recent work suggests that increased 
activity of the transsulfuration pathway is required for the extension of lifespan 
by DR in Drosophila (18). Indeed, hydrogen sulfide production by the 
transsulfuration pathway is associated with extension of lifespan by DR in 
yeast, flies, and mice (19). 
There is thus an emerging role of dietary protein, and of specific AAs, in 
modulating the health benefits of DR in humans, suggesting the potential of 
interventions in protein intake to improve human health. 
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II. Protein content and AA imbalance 
In agreement to what is observed in DR animals, restriction of dietary protein 
or AAs reduces wound healing capacity and increases susceptibility to viral 
infections (20). Also in accord with what is seen in DR animals, protein-
restricted mice have protected cognitive function and live longer (3,21). 
However, in contrast to DR animals, protein-restricted mice can show an 
increase in body fat and insulin resistance (3). Decreasing dietary protein also 
increases body fat in humans (22), but a high intake of dietary protein and 
AAs promotes insulin resistance and adversely perturbs glucose homeostasis 
(23). In consequence, only 10-15% of energy intake as protein is 
recommended for humans (30), although for weight loss management the 
absolute amount of protein consumption is of greater importance than the 
percentage of energy (22).  
 
The effective protein uptake depends on the efficiency of a protein’s usage. 
This is the result of the combined effects of (i) how much protein is ingested 
and metabolized, (ii) its essential to non-essential AA ratio (EAA:NEAA), and 
(iii) its precise AA composition (24). Adequate protein intakes can be achieved 
with lesser amounts of high quality protein than of low quality protein, where 
quality is determined by its efficiency for anabolic traits. The effects of a 
dietary AA imbalance are more severe when overall AA intake is low (25), as 
AA imbalances further decrease AA usage. A low EAA:NEAA can also be 
inefficient for anabolic traits at low AA intakes. Therefore, the protein content 
and effective macronutrient ratio of protein to carbohydrates and fats greatly 
depends on the AA proportions of the ingested protein. Consequently, the AA 
proportions of a diet are critical for health, both through effects on total protein 
usage, and through mechanisms mediated by specific AAs. We highlight the 
metabolic fate of AAs, from ingestion to effects upon metabolism and health, 
in the following sections. 
 
III. Multivariate complexity of defining a dietary AA-imbalance 
Identifying a diet with a healthy mixture of nutrients is complicated by the 
multivariate nature of diets, which poses a challenge for experimentation, and 
by the synergistic effects of multiple essential macro- and micro-nutrients (26). 
Accordingly, complex interactions between individual AAs render phenotypic 
responses to different AA ratios hard to interpret. Moreover, an interaction of 
AAs with other nutrients such as vitamins can also modulate metabolism (27), 
which further increases the complexity of nutritional space and confounds 
biological interpretations. Consequently, defining a balanced AA intake is a 
challenge. 
 
To simplify the nutritional landscape, recent methods dissect nutritional 
interactions and their physiological effects in multidimensional space (2,26). 
Such a representation of nutritional space, called the geometric framework, 
can better describe the responses of metabolic, lifespan, and other traits, and 
can reconcile apparently contradicting results (2,26). Multi-dimensional 
approaches are desirable but sometimes impractical, and progress can also 
be impeded due to the lack of standardized methods. In flies, the recent 
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development of holidic diets enables the accurate analysis of the effects of 
single dietary AAs (46), and such tools would benefit work in other model 
organisms such as mice and rats. This kind of experimental standardization 
will aid the systematic analysis of multivariate AA interactions and their effects 
on health and ageing.  
 
It is difficult to discern the physiometabolic effects of subtle AA imbalances 
that occur under conditions of normal nutrition, which is usually characterized 
by the intake of varied dietary protein sources. Even in laboratory model 
organisms, with carefully controlled conditions using chemically defined diets, 
problems can persist. Autoclaving and irradiation, both common sterilization 
steps in laboratory rodent food preparation, can degrade certain AAs including 
lysine, methionine, and cysteine, as well as vitamins like A and B1 (27). In 
everyday human nutrition, food processing such as cooking may alter the AA 
contents of a protein source. Food texture can also have dramatic effects 
upon metabolism, as soft foods increase nutrient efficiency and adiposity. In 
humans, ageing also leads to anorexia and weight loss, largely due to the 
progressive functional decline of the digestive system (138), which also likely 
results in deceased AA absorption. All these factors render practical diet 
design challenging.  
 
 
IV. Anabolic traits and their experimental assessment 
Although health and lifespan responses to AA sources are sometimes 
evaluated, experimentally the balance of an AA source is typically defined by 
its ability to maximize production traits (27).  
 
With regards to the growth effect of single EAA limitations in vertebrates, the 
principle of the minimum is typically applied. The principle states that when all 
essential nutrients required for growth are abundant in a diet except for one, 
the limiting essential nutrient, incremental additions of this limiting essential 
nutrient only will increase growth (28). For EAAs, this has been repeatedly 
demonstrated experimentally in rodents (24). In addition, the principle is 
coupled to the law of diminishing returns, according to which each succeeding 
increment of the limiting essential nutrient will produce a smaller increment of 
growth than the preceding increment (28,29). However, the nature of the link 
between anabolic traits and long-term health is complex and is discussed 
below with respect to protein and AA intakes. 
 
V. Link between anabolic traits and long-term health? 
Growth: Both DR and protein restriction can suppress growth and extend 
lifespan in rodents (3,5,24). The developmental theory of ageing holds that a 
prolonged lifespan is caused by retarded development, and this notion was 
quickly adopted as an explanation of the lifespan response to DR (31). In flies 
and mice, the reduced growth observed upon DR or protein restriction 
respectively seems to be effected by a reduced cell number, implicating the 
suppression of IIS (32,33). Life-extending tryptophan or methionine 
restrictions also reduce growth in mice and rats via reduction in circulating 
IGF-I (13,14). Reduced IGF-I signaling modulates the negative correlation 
between body size and lifespan in mice (34) and dogs (35). Several rodent 
 9 
studies show a negative correlation between body size and longevity in both 
genders (34,36) , as do several genetic models of extended longevity under 
reduced IIS (37). All these observations together suggest an inverse 
correlation between growth in body size and lifespan.  
 
However, growth depression is not a prerequisite for lifespan extension. Body 
growth has been uncoupled from longevity both in mice and in flies (37). 
Thus, manipulations of growth signaling can extend longevity with no effect on 
body growth. Moreover, although anabolic traits are often used in the 
nutritional evaluation of a dietary protein, such traits are not reliable predictors 
of health during ageing. In rodents, some AA imbalances that do not cause 
growth depression can be detrimental for health and cause fatty infiltration of 
the liver (24). Therefore, reduction in growth signals can cause growth 
suppression and lifespan extension, but the former is not a prerequisite for the 
latter. From this perspective it remains possible that specific dietary AA 
intakes could optimize anabolic traits and lifespan, avoiding trade-offs 
between them. 
 
Reproduction: Fecundity depends on nutrient utilization, and animal models 
are used to evaluate the link between fecundity and lifespan. In flies, DR 
reduces fecundity and increases lifespan (38). Fecund females allocate much 
of their ingested nutrients to reproductive processes, a proportion diminished 
in DR flies (39). In rodents, some long-lived models show a marked 
reproductive capacity reduction (38). Apart from extending rodent lifespan, 
protein restriction also suppresses fecundity (27). Reproductive output is also 
negatively associated with lifespan in dogs (40) and humans (41). However, in 
several fly models lifespan extension is not characterized by a lower 
reproductive output (38). Supplementing methionine in a methionine-restricted 
fly diet can rescue fecundity with no lifespan shortening (8), indicating that 
dietary modulation of AAs can promote longevity without impairing fecundity. 
Therefore, suppression of reproduction may not be indispensible for lifespan 
extension, and the design of diets that optimizes both traits is possible. 
 
 
3. Amino acids: from ingestion to regulation of metabolism and health 
 
3.1. Absorption and systemic availability of amino acids 
 
I. Dietary protein and amino acid absorption  
The intake of AAs is achieved through the consumption of either whole protein 
or free AAs in the diet. Following their ingestion, the identity and amount of 
the AAs that become available to cells and tissues depends on AA absorption 
by epithelial enterocytes. The digestibility of whole dietary proteins is 
confounded by numerous factors (42), which makes it difficult to establish the 
identity and amount of bioavailable AAs after the ingestion of whole protein 
foods (43). Yet, whether derived from digested peptides or free AA diets, AAs 
show substrate antagonism and other physicochemical properties that can 
complicate estimations of their availability (42-44). In contrast to whole protein 
diets, free AA diets avoid many of the confounding factors influencing whole 
protein digestion, and are more readily absorbable (45-46). Moreover, in 
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contrast to oligopeptide transporters, characterization of the free AA 
transporters in the human intestinal epithelium is comprehensive (44). 
Therefore, free AA diets are more suitable for the assessment of post-
absorptive effects of dietary AAs upon metabolism, health, and ageing. 
 
II. Dietary AAs and the microbiota  
The uptake of AAs is influenced by gut bacteria, and this can greatly affect the 
response to a dietary protein or AA source. Instead of epithelial enterocytes, 
free AAs in the gut’s lumen may first encounter gut microbes. Gut bacteria are 
both consumers and producers of AAs, but the net exchanges between host 
and microbiota of specific AAs, and the factors that influence this exchange, 
are not yet fully understood (47-48). Nevertheless, many AA exchanges 
between the host and the microbiota have been characterized. Gut bacteria 
synthesize all essential AAs (EAAs), and contribute up to 10% of mammalian 
plasma metabolites, including the EAAs tryptophan, phenylalanine, and lysine  
(48-49). Although such contributions for other EAAs are not yet described, 
they are likely to occur. In addition, during the host-colon nitrogen cycle, 
microbes further contribute towards AA re-absorption by the host (48). 
However, when rodents with a gut microbiota are fed single EAA-deficient 
diets, their health quickly deteriorates, which suggests that bacterial EAA 
contributions are modest (24). The effects of the deficiency also depend on 
the identity of the AA deprived (24), and on how much of each EAA gut 
bacteria can provide to the host. However, ruminants with a rumen microbial 
load that is able to synthesize all EAAs, still require an ample dietary AA 
supply to achieve high levels of growth or milk production (50). Therefore, the 
contribution of EAAs from gut bacteria to the host appears limited. In contrast, 
the microbiota consumes substantial amounts of AAs, with up to 50% of fecal 
nitrogen being of bacterial origin (1,4). However, more work is needed to 
establish how much of each ingested AA can be used by gut bacteria (47). 
Taken together these observations demonstrate that the gut microbiota can 
shape AA availability to the host. This can be especially important in low 
protein diets, because small changes in AA availability can have a 
proportionally greater effect on the available AA profile. In turn, this can also 
influence the useable dietary protein and the macronutrient ratio, which 
shapes health and ageing.  
 
Changes in the microbiota are also associated with the risk for obesity, 
diabetes, and heart disease, and in mice DR enriches microbiota phylotypes 
associated with increased longevity (51). Gut bacteria adapt to ingested 
nutrients and can shift focus from dietary carbohydrate to dietary AA 
metabolism (52), while they also benefit from ample dietary fibre, which 
increases fecal nitrogen and decreases net AA uptake by the host (47). By 
adapting to macronutrients and metabolizing fibre, gut bacteria can stimulate 
the secretion of intestinal growth factors or satiety hormones (53,54). Apart 
from the health risks of a chronically over-stimulated growth axis, such 
interactions also complicate estimations of efficiency of dietary AA sources 
that rely on the evaluation of anabolic traits (growth) or behavioural traits (food 
intake). Also, the metabolism of AAs by gut bacteria may be influenced by 
circadian rhythms, or the host’s age and immune status. Due to such 
complications, quantifying the net AA exchanges between host and microbiota 
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is easier in animals with a small number of gut bacteria species and 
chemically defined diets, such as fruit flies (46,53). Understanding of the 
factors affecting AA usage by gut bacteria, the mechanisms by which gut 
microbes influence AA availability to the host and the health consequences, 
will be aided by approaches in which the amount or composition of the 
microbiome is experimentally manipulated. 
 
III. The splanchnic bed and systemic AA availability  
The amount of each AA that becomes systemically available is critical for 
metabolism, affecting health through AA-sensing mechanisms discussed in 
the following sections. However, this amount greatly depends on how many 
AAs are metabolized immediately after absorption in the gut. Once absorbed 
by enterocytes, free AAs enter into the splanchnic bed (SB), which comprises 
the gut, liver, spleen, and pancreas, where free AAs can be metabolized. In 
general, up to a third of all dietary AAs are metabolized by the SB (47), greatly 
shaping the AA profile that reaches circulation to become systemically 
available. Metabolism of AAs in the SB also depends on AA identity. Despite 
arterial supply of AAs, enterocytes greatly rely on dietary AAs (55), and a low 
AA intake may contribute to enteral atrophy. Enteral usage of threonine is 
particularly high, presumably for the synthesis of threonine-rich mucins 
(47,55). In the liver, methionine enters many transulfation, transmethylation, 
and folate metabolism reactions (55). Glutamate, valine, isoleucine, leucine, 
and phenylalanine are also largely used by the SB. For all these AAs, an 
estimated 35%-100% of dietary intake is used by the SB, never reaching 
systemic circulation (47,55). In contrast, arginine, alanine, tyrosine, and 
proline undergo minimal usage by the SB (55). An AA’s conformation can also 
determine its SB usage. In flies, mice, and rats, D- and L-methionine are 
highly bioavailable, while in humans D-methionine is only ~30% bioactive 
(24,56-57). In contrast, all other AAs are fully usable only in the L- form across 
the four species (24,56). Thus, SB metabolism of free AAs substantially 
affects their systemic availability depending on the individual AA’s identity. 
 
Following their passage through the SB, free AAs pass into circulation, to 
become part of the free AA pool. Free AAs represent a very small fraction of a 
body’s total AA contents, but are metabolically significant as they form the 
systemically available AA profile. Indeed, free AAs are associated with 
lifespan across species. In flies low levels of glutamine, lysine, and alanine 
are linked to extended longevity (58). In mice, circulating metabolites including 
glutamine, methionine and proline decrease with age (59). This decrease is 
countered by acute DR, which increases circulating methionine, glutamine, 
alanine, and valine indicating a shift towards gluconeogenesis and energy 
conservation (60). However, an opposite metabolic shift has been suggested 
in dogs, where lower levels of isoleucine, leucine, phenylalanine, and valine 
are associated with the health benefits induced by DR (61). The same 
association has been made in humans too, where a plasma decrease in 
isoleucine, leucine, valine, lysine, phenylalanine, and histidine was linked to a 
reduced carbohydrate metabolism and an increased AA catabolism (62). 
Moreover, depleted levels of circulating methionine and BCAAs have been 
observed in long-lived IIS mutant mice (63). Finally, in mice elevated 
circulating BCAAs stimulate their catabolism in the liver (15). Thus, it is 
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currently difficult to interpret the mechanisms involved in plasma AA changes 
with age or with DR, or the consequences of these changes for health. Some 
possible mechanisms linking such free AA modulations to lifespan are 
discussed in more detail in following sections. 
 
From circulation, free AAs can enter interstitial fluids and cells, to become part 
of tissue intracellular pools. Although the circulated free AA pool is available 
to all tissues reached by circulation, cell-specific AA availability depends on 
AA transporters whose abundance can vary between cell types (64-65). 
Abundance of transporters is well characterized for enterocytes, hepatocytes, 
pancreocytes, nephrocytes, and in the brain, as is substrate antagonism 
between AAs for transporters (44,65-66). Thus, despite equilibrium between 
circulatory and intracellular pools for most free AAs, substantial differences in 
concentrations between the two pools are seen in some cases. In humans, 
glycine, glutamate, and glutamine are 10-50 times more concentrated in 
intracellular pools (4). And it is also noteworthy that the free AAs in a tissue do 
not match the AA composition of the tissue’s proteome. In rat muscle, 
compared to protein-bound AAs, there are depleted levels of phenylalanine, 
methionine, and BCAAs (4). Therefore, circulating, intracellular, and protein-
bound AA profiles differ significantly, but circulating and intracellular AAs 
fluctuate more dynamically and play a prominent metabolic role.  
 
The dynamics between transporter abundance and tissue-specific AA 
availability need more clarification, as do the effects of bidirectional transport 
between specific AAs, such as glutamine and leucine (155) upon AA tissue 
specific AA availability. Nonetheless, some physiological effects of AA 
antagonisms are clear. Antagonisms between the BCAAs can result in growth 
depression upon supplementation of one of these three AAs in the diet (24). 
Similarly, antagonisms between lysine and arginine can suppress growth 
upon addition of lysine or arginine only in the diet (24). Excess leucine or 
methionine deppress rat growth independently of food intake, with excess 
leucine increasing the growth requirement for tryptophan (24). However, there 
is a lack of long-term studies, and the effects of an AA imbalance-induced 
decrease in growth signaling upon health and lifespan await further study.  
 
IV. Metabolic fate of ingested amino acids 
The metabolic fate of intracellular AAs is important in determining the effects 
of AA intake upon health and ageing. An outline of AA metabolism is given in 
Figure 1. Once in the splanchnic bed, free AAs can be used for protein 
biosynthesis (e.g. in liver or intestinal muscle cells), or can be broken down to 
their carbon skeleton and amine groups. Amine groups are typically excreted, 
but carbon skeletons can have a diverse fate. They can be used in the 
biosynthesis of acetyl-coenzyme A (acetyl-CoA) or acetoacetyl-CoA, the main 
precursors of fatty acids, which are in turn stored as triacylglycerides (TAGs) 
in adipose tissue. Alternatively carbon skeletons can be used to synthesize 
pyruvate and oxaloacetate, the precursors of glucose (stored as glycogen) 
fueling the tricarboxylic acid (TCA) cycle. Finally catabolism of the carbon 
skeleton can also be used for cellular respiration and energy production in the 
form of ATP. Those AAs not metabolized in the splanchnic bed can enter 
circulation, from where they can be absorbed by cells and tissues. 
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Consequently, the proportion of AAs in the diet can affect many of these 
metabolic pathways. This aspect is discussed separately for AA limitations 
and excesses in the following sections.  
 
3.2. Detection of AA limitations 
 
The sensing of both circulating and intracellular free AAs occurs through 
various mechanisms, at both the cellular and systemic levels. These two 
modes of AA-sensing determine many of the metabolic and physiological 
responses to fluctuations in AA availability.  
 
I. GCN2-dependent detection of AA limitation  
A metabolic response to limited AAs can only occur after their limitation is 
detected. In flies, nutrient perception involves chemosensory sensila, 
enteroendocrine, and gustatory signals (67). The consequences of the fly’s 
nutrient sensing can be uncoupled from its actual food intake, because 
stimulating odorant receptors can reverse the benefits of DR upon lifespan 
independently of food or protein intake (68). The fly’s selection of an AA 
source is partly mediated by the serine/threonine-protein kinase general 
control nonderepressible 2 (GCN2) acting in dopaminergic neurons in the 
brain (69). The mammalian central chemosensor detecting decreased 
circulating essential AAs is found in the brain’s anterior prepiryform cortex 
(APC) (70). Here, low levels of EAAs stimulate GCN2, which suppresses 
anabolism and promotes catabolism through the AA response (AAR) pathway 
(70,72,87) (Figure 2). This GCN2 activation is independent of the AA’s 
identity, because GCN2 senses the AA deﬁciency by binding non-specifically 
to any uncharged transfer RNA (70,73). However, branched chain AAs, and in 
particular leucine, the most abundantly used AA in mammalian proteomes, 
appear to play a predominant role (74). Upon binding an uncharged tRNA, 
GCN2 changes its conformation to promote inhibitory phosphorylation of its 
primary downstream translation activator, the eukaryotic initiator factor 2 
alpha (eIF2α) (70). This leads to global down-regulation of transcription and 
translation through changes in mRNA levels or mRNA stabilization, growth 
arrest and reductions in lipid and carbohydrate anabolism, activation of AA 
transporters (e.g. asparaginase synthetase ASNS), and changes in neuronal 
glutamatergic activity, intracellular calcium and GABAergic signaling 
(64,70,72,75). A common downstream effector of GCN2 activation upon 
methionine or leucine restriction is fibroblast growth factor 21 (FGF21), which 
represses liver fatty acid synthesis and increases fatty acid mobilization 
(13,76).  
Although GCN2 is a key modulator of the systemic response to decreased 
levels of circulating AAs, it is also expressed across tissues and may also act 
in a cell-autonomous manner (70). In rodents, three isoforms of GCN2 are 
found: , , and . The  and  isoforms have no functional GI (GCN2/Impact) 
domain to bind GCN2 to its activator GCN1, and are expressed tissue-
specifically, while  has a functional GI domain and is expressed similarly 
across tissues (73). However, mice lacking GCN2 specifically in the brain fail 
to show the normal aversive behaviour towards AA-imbalanced diets. AA 
sensing in the APC thus overrides peripheral GCN2 activity with regards to 
feeding behaviour (72). Therefore, low circulating AAs result in stimulation of 
the AAR pathway through the activation of GCN2, which orchestrates cell-
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autonomous and non-cell autonomous effects to promote catabolism, 
suppress anabolism, and thereby induce a metabolic maintenance mode.  
 
II. GCN2-independent detection of AA limitation  
Although much evidence supports a role for GCN2 in the sensing of ingested 
AAs, some studies cast doubt over its significance in the physiological and 
behavioural responses to AA-deficient foods. Recently, GCN2 has been 
shown to have no effect on the detection of AA-deficient diets in mice (145). In 
addition, sensing of AAs such as alanine or glycine in hypothalamic neurons 
also occurs via excitatory signals that are modulated within seconds from the 
moment an AA is supplied (146). Such response mechanisms are GCN2-
independent, as transcriptional changes modulated by GCN2 would likely 
require a longer time period. Indeed, some preliminary findings in GCN2 
knockout mice indicate that the response to methionine restriction is not 
dependent on GCN2 (13). Therefore, given the central role of the 
hypothalamus in modulating feeding behavior, obesity, and metabolism (152), 
it will be interesting to see how different ingested AAs give rise to an 
organism’s hypothalamic and consequent metabolic response to ingested 
AAs.  
Dietary AA restriction also regulates gene expression via multiple GCN2-
independent pathways, including transcriptional (e.g. Cxcl10) or post-
transcriptional (e.g. Dusp16) responses (72,77). Although the molecular 
mechanisms behind the activation of such responses by low AAs are not 
known, such changes are able to increase catabolic processes and metabolic 
efficiency independently of the GCN2-mediated AAR response. For example, 
efficiency of AA uptake is increased by up-regulation of asparagine 
synthetase ASNS, or of plasma membrane AA transporters such as the 
neutral AA transporters SNAT2 and LAT-1 and the cationic AA transporter 
CAT-1 (64,72,78). Other GCN2-independent responses can include 
transcription factor adjustments (ATF2-5, C/EBP and other ATF/CREB TFs), 
and changes in ribosomal proteins that affect translation (64,72,78). Although 
GCN2 is the only kinase exclusively responsive to AA deprivation, 
phosphorylation of eIF2 can also be effected by other kinases including 
heme-regulated inhibitor kinase (HRI), double-stranded RNA-activated protein 
kinase (PKR), and PKR-like endoplasmic reticulum-resident kinase (PERK), 
and considerable overlap has emerged in the activation of downstream 
effectors between PERK and GCN2 upon methionine restriction in mouse 
liver (75). Moreover, internal ribosomal entry sites (IRESs), such as that in the 
CAT-1 mRNA, allow preferential translation by phosphorylated eIF2, and the 
role of such IRESs in PERK or GCN2 activation also requires further 
characterization (75). Another GCN2-independent mechanism may involve 
the AMP-activated protein kinase AMPK, which senses low-energy states by 
detecting high AMP levels (79). AMPK functions both cell-autonomously and 
non-cell-autonomously and is also activated upon low AA status (71,79). 
Importantly, increased AMPK activation extends worm and fly lifespan (79). 
 
The dynamics of GCN2-independent responses can vary. As mentioned, 
sensing of supplied AAs by hypothalamic neurons can occur within seconds, 
thereby comprising a rapid response (146). In contrast, other modulators can 
vary across a wide range of time. For ASNS, a translational surge upon AA 
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limitation is followed by a more sustained transcriptional activation (64). 
Moreover, plasma AA responses to dietary AA limitations indicate that the 
limited AA drops in the plasma initially, but after several days its levels are 
restored (80). As a response to an AA-imbalanced diet, growth and food 
intake depression also subside after several days (81), perhaps through 
reconstitution of hormonal homeostasis (discussed below). In contrast, short-
term responses relying on GCN2 do not require hormonal adjustments (70). 
Thus, although several GCN2-independent responses to limited AAs have 
emerged, further clarification of the molecular mechanisms and 
characterization of the short- versus long-term responses is needed. 
 
 
III. Effects of AA limitations on ageing  
All limitations or excesses of dietary AAs are sensed in a way that modulates 
anabolic and catabolic processes and, ultimately, homeostasis. Suppression 
of anabolism and growth signaling can extend lifespan and is induced by AA 
limitations. The identity of essential AAs is conserved between rodents and 
humans, and human cell culture work on AA limitations shows consistent 
results to murine cell systems implying conserved molecular mechanisms 
(135). In rodents, methionine and tryptophan limitations suppress anabolism 
and translation, and promote catabolic processes (13). Glucose, insulin, 
thyroid hormones, and IGF-I levels are also reduced in methionine-restricted 
mice. Yet, generally, low levels of circulating AAs reduce IGF-I function largely 
independently of their identity (83). Lack of the AA building blocks for anabolic 
traits also results in induction of apoptosis by IGF-I, which activates the 
apoptosis inducer CHOP (64). Stimulation of apoptosis aids the recycling of 
molecular building blocks, including AAs. Therefore, AA limitations deplete 
growth signaling and can thus induce a maintenance mode that benefits long-
term health. 
 
By increasing catabolism, methionine or tryptophan restrictions also reduce 
fat storage in rodents (13,14). However, although across multiple organisms 
and humans DR results in leanness or rescue from obesity to confer multiple 
metabolic advantages that favour longevity, the role of fat loss per se in 
promoting health is not clear. For instance, diets low in protein increase 
adiposity in mice because of increased food intake, but these mice are as 
healthy as DR mice (2,3). Additionally, the ability of animals to maintain their 
adiposity despite DR appears to mediate the beneficial effects of DR (84). The 
decline of mTOR expression with age in rat white adipose tissue is also 
prevented by DR (85). Therefore, as the role of fat deposition in DR is 
unclear, and given that different types of fat affect health differently, the role of 
fat deposition in mediating the health benefits of protein or single AA 
restriction requires further investigation. 
 
IV. TOR-dependent detection of AA abundance 
In mammals, the cell-autonomous AA response upon excess of AAs relies 
primarily on the mammalian target of rapamycin (mTOR), which occurs in two 
complexes, mTORC1 (rapamycin/nutrient sensitive) and mTORC2 
(rapamycin/nutrient insensitive). Absence of AAs results in the TORC1-
inhibitory recruitment of the tuberous sclerosis protein TSC2 onto the 
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lysosomal membrane (149). Mechanisms of activation of mTORC1 in the 
presence of AAs are shown in Figure 3. Sensing involves a complex interplay 
between numerous molecules recruited in or around the lysosome, which is a 
key site of AA recycling, and intracellular/intravacuolar AA sensing (74,86). 
Intracellular AAs prevent the inhibitory association of Sestrins with the 
GATOR2 complex (87)(150). This lowers GATOR1’s GAP activity upon Rag 
A/B, which is bound to Rag C/D and is important for the activation and 
translocation of TORC1 onto the lysosomal membrane (87). Intracellular AAs 
are taken into the lysosome by transporters such as SLC38A9, which has a 
particularly high affinity for arginine (88). This transport induces 
conformational changes in the endolysosomal V-ATPase, which dissociates 
from the Ragulator/Rag complex (88). The Ragulator then enables the 
activation of Rag A/B through its guanine nucleotide exchange factor activity 
(88). Intracellular AAs can also promote the GTPase activity of the folliculin 
complex FLCN/FNIP (89), which results in the RagC/D complex being loaded 
with GDP, and stimulates Arf1 and Rab5, which are involved in intracellular 
trafficking inducing TORC1 activation (90).  
 
The identity of the AA also determines how it is sensed by TORC1. Leucine 
activates Rag A/B through Sestrin 2 (150), glutamine sensing involves Arf1 
and the V-ATPase, but not Rag A/B, and arginine sensing involves SLC38A9 
(91). Other factors involved in TORC1 activation by AAs may involve the 
kinase Vps34 and SH3BP4 (86). Importantly, inhibition of mammalian TORC1 
activation extends lifespan and, although activated TOR is critical in regulating 
adiposity by inducing lipid synthesis (86), insulin resistance is effected 
primarily by mTORC2 (92). The interplay between TOR and AMPK in sensing 
AAs also requires further characterization. Inhibition of rat muscle mTORC1 
with rapamycin has no effect on AMPK, but activation of AMPK suppresses 
mTOR signaling and insulin resistance (93). Accordingly, reduced AMPK 
activity precedes mTOR activation by glucose or leucine, leading to insulin 
resistance (93).  
 
As discussed for GCN2, not all AAs stimulate mTORC1 equally. In rodents 
leucine is a particularly strong activator (74). It has been reported that 
intracellular leucine is uniquely sensed by leucyl-tRNA synthetase (LeuRS), 
which activates the mTORC1 complex (Figure 3) (94). Nonetheless, it is now 
known that Sestrin2 possesses a leucine pocket to bind to, and sense, 
cytoplasmic leucine levels (151). Some obese animal models deplete their 
circulating glucogenic AAs, leaving higher circulating sulphur (95) and BCAAs 
including leucine (15), which can result in chronic TOR activation. In contrast, 
a low protein diet decreases circulating BCAAs and mTOR activation (3) and 
sensitizes animals to AA imbalances (24). Importantly, TOR activation can 
stimulate the secretion of hunger or satiety hormones in the GI tract and brain, 
such as ghrelin and leptin, respectively (23), and recent evidence suggests 
TOR is a mediator of the enteroendocrine hormonal responses to dietary 
proteins and AAs (96). Therefore a regularly high dietary intake of AAs 
induces chronic mTOR activation, which is detrimental to health and lifespan, 
whereas AA imbalances or limitations can inhibit TOR. However, TOR 
activation with respect to single AA modulations requires further elucidation 
both in invertebrates and vertebrates. 
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V. TOR-independent detection of AA abundance 
Multicellular organisms have both intracellular and extracellular AA sensors, 
as well as neural sensors that respond to the intake of nutrients. Although 
TORC1 senses endocellular AAs and can stimulate satiety signals, in the GI 
tract extracellular AA sensors also play a prominent role. At least some 
mammalian G-protein-coupled receptors (GPCRs) are transceptors. 
Transceptors are transmembane transporters of nutrients, including AAs, that 
also act as receptors involved in inducing endocellular signaling. In mammals, 
GPCR receptors of the T1R family are activated mostly by L-AAs in the 
digestive tract (100), and even modulate TOR signaling independently of 
intracellular AA levels (65). Transmembrane GPCRs in enteroendocrine cells 
can stimulate the release of appetite-regulating incretins or decretins (98-99). 
Specifically, high luminal AA concentrations increase secretion of satiety 
incretin hormone GLP-1 by enterocytes (101). Additionally, in response to 
food or AA intake, density-, stretch-, and other chemo-receptors in the GI tract 
release neural signals of satiety to the CNS (54,97). Cholecystokinin (CCK) is 
secreted in response to luminal AAs, and CCK receptors stimulate vagal 
afferent signals to the nucleus of the tractus solitaries (NTS) of the brainstem, 
which relays signals to the hypothalamus (97). Other secreted peptides by the 
GI tract or along the splanchnic bed include leptin, insulin, and peptide YY 
(PYY), which suppress appetite in response to bulk food intake or protein 
intake, while ghrelin increases it (97) (Figure 4). Furthermore, recent evidence 
strongly supports unique ingested amino acid-specific signaling to the CNS, 
involving vagal afferents and the area postrema (148). All the above 
responses have some degree of conservation between invertebrates and 
vertebrates as similar mechanisms are involved in the fly’s intestinal nutrient 
sensing (67). Thus, neural and hormonal modulations in the gut can function 
independently of intacellular AA sensing by TOR. In this way, ingested AAs 
trigger the release of hormones to regulate homeostatic processes in the 
whole organism (Figure 4).  
 
VI. Responses to AA surpluses that affect physiology and ageing 
High protein diets increase satiety and decrease food intake in many 
organisms, including flies (26), mice (2), and humans (22), an effect referred 
to as ‘protein leverage’ (2), with the main driver of appetite a target protein 
intake. Therefore the reduced obesity and insulin resistance of animals and 
humans fed a high protein diet ad libitum can be explained by their decreased 
food intake (23). However, dietary AA-induced chronic stimulation of the 
IIS/TOR pathways is detrimental for health (3,23,71,86,102). In yeast and 
worms, AA restrictions can inhibit TOR and extend lifespan (5,103,104). 
Inhibition of TOR by rapamycin or of S6 kinase (S6K), a downstream effector 
of TOR, also extends fly and rodent lifespan (102). Another main effector of 
mTOR is the translation repressor 4E-BP, which is activated upon TOR 
inhibition by DR in flies (102) or methionine-restriction in rodents (105). In 
humans, high levels of protein or AA intake also result in TOR activation (23) 
and insulin secretion (22), while excess acidifying AAs or sulphur AAs also 
raise blood pressure (22). With ageing, mTOR activity in mouse hypothalamic 
neurons increases, silencing anorexic neurons and contributing to age-related 
obesity (106). Moreover, TOR function can affect diverse systemic processes, 
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including cell and tissue growth signaling, immune function, proteostasis, 
neurodegeneration and cognitive function, tissue and stem cell physiology, 
and others (86,102). Thus, activation of TOR by high AA intakes can in the 
long-term be detrimental for health, promoting age-related disease such as 
neurodegeneration (107).  
 
Although AAs promote growth signaling and TOR, excess AAs can also 
suppress growth, and therefore growth signaling, through antagonistic 
interactions. Mechanistically, this may occur if an AA is ingested in amounts 
that saturate specific AA transporters due to the AA’s higher abundance, 
substrate affinity, or kinetics. In this case, it is possible that in some tissues 
intracellular levels of out-competed AAs become limited, thereby triggering the 
AAR to inhibit anabolic processes. Specific examples of moderate additions of 
AAs inhibiting growth in rodents were discussed earlier. Unpublished data in 
our laboratory also indicate that moderate additions of AAs can inhibit growth 
or growth signaling in both flies and mice. Importantly, such inhibitions of 
growth signaling may also affect health and longevity. In worms, addition of 
some AAs extends lifespan significantly through TOR inhibition (103). 
However, the identity of the AA is important, as addition of some AAs in the 
worm’s diet had no effect, or even decreased lifespan drastically (103). In 
rats, an excess of threonine can be well tolerated but a similar excess of 
tyrosine can cause pathological lesions (24). Therefore the identity of the AA 
ingested in excess determines its effects upon health. More life-long studies 
will further clarify these interactions upon long-term health and ageing. 
 
VII. Convergence of AA sensing pathways 
There are many interactions between the multiple nutrient and AA sensing 
pathways discussed above (77). Phosphorylation of some translation initiation 
factors by TOR changes their conformation to allow accessibility by other 
kinases or phosphatases (including GCN2 downstream effectors) (108). 
Protein synthesis inhibition by GCN2/eIF2α stimulation occurs in conjunction 
with mTOR inhibition, and some cancer drugs deplete circulating AAs and 
trigger GCN2 to decrease mTORC1 signaling (109). Indeed, upon deprivation 
of AAs GCN2 induces the expression of Sestrin 2, thereby blocking the 
activation of mTORC1 (154). In yeast, the AAR pathway is most responsive 
when mTORC1 is inhibited by rapamycin (73). In worms, there is also a 
convergence of GCN2 and TOR upon AA limitation towards inhibition of 
global translation and down-regulation of FOXO transcription factors (110). 
Stimulation of FOXO transcription factors modulates the life-extending effect 
of IIS downregulation across species (5,106). Therefore, the orchestration of 
these two nutrient sensing pathways (TOR and GCN2) modulates AA 
sensing, although a detailed characterization of this interaction, especially 
with respect to individual AAs, remains to be established. 
 
VIII. Food aversion, protein leverage, and growth signaling  
Because imbalanced protein sources prevent the usage of excess and 
therefore total AAs, adequate protein intakes can be achieved with lesser 
amounts of high quality protein than of low quality protein. In order to achieve 
the target AA intake as driven by protein leverage, a less usable protein will 
therefore be consumed in greater amounts than a highly usable protein. For 
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instance, whey promotes growth more than does casein, and also induces a 
higher satiating effect in humans (111-112). However, imbalanced AA sources 
can result in deficiencies for specific essential AAs, and so animals must also 
have protective aversive responses to direct them to alternative, balanced AA 
sources (25). Thus the motive for increasing the intake of an imbalanced AA 
diet to achieve a target protein consumption may conflict with the motive to 
avoid a detrimentally imbalanced AA intake. The thresholds distinguishing 
between such conflicting motives are unclear, as is the impact of the 
imbalanced AA’s identity on such effects.  
 
Rodents are more sensitive to limited than they are to excess AAs. Very small 
AA limitations are detectable by rats, representing a 0.009% w/w change in 
the diet (70). Such limitations are not reflected in the plasma, but are seen in 
the APC region within 15 minutes of feeding on the imbalanced diet, resulting 
in loss of appetite (70). In contrast, growth suppression is detectable upon 
changes that represent >0.1% w/w of the limiting AA in the diet (24). In 
addition, ad libitum fed rodents on severely AA-limited diets decrease their 
food intake and growth but, if the animals are made to eat equal amounts, 
growth returns to normal (24). Therefore, appetite is more malleable in 
response to ingested AAs than is growth signaling. Moreover, responses to 
ingested AAs also depend on the identity of the imbalanced AA. Restriction of 
specific AAs (lysine, threonine, or isoleucine) alters food preference but not 
food intake in rats (70) . In mice, excess consumption of some AAs (e.g. 
methionine, tryptophan) suppresses food intake and growth more than does 
excess intake of others (e.g. threonine) (24). Therefore, the response to an 
imbalanced AA ingestion depends on the AA identity and on the physiological 
(e.g. growth) or behavioural (e.g. appetite, food choice) trait assessed. Further 
understanding of these aspects and interactions will be important in 
elucidating how AA modulations regulate metabolism and ageing, and in 
designing nutritional applications for humans. 
 
IX. Distinct bioenergetic and metabolic roles of amino acids  
Because of their different molecular structures, free AAs are broken down 
through distinct biochemical reactions. According to their catabolism, AAs can 
be glucogenic (all AAs except lysine and leucine), leading to the generation of 
glucose, or ketogenic (lysine, leucine), resulting in ketone bodies, although 
some AAs can be both (isoleucine, threonine, phenylalanine, tyrosine, and 
tryptophan). Glucose and ketones are the body’s main energy sources, and 
cellular energy production from AA catabolism can represent 10-15% of total 
energy production (22). Importantly, the energy density of glucose is typically 
lower than that of ketones. Moreover, the energy expenditure for the 
metabolism of different AAs varies. Glutamate is the most energetically 
efficient AA (120), which may explain the central role of glutamate in providing 
TCA cycle precursors (66). Each AA also has a different metabolic efficiency 
for anaplerotic reactions, i.e. reactions that produce TCA cycle intermediates 
from precursors including AAs. Therefore, the metabolism of specific AA can 
uniquely affect energy homeostasis, which may impact on ageing. In worms, 
dietary supplementation with the ketogenic beta‐hydroxybutyrate (103), the 
ketone derivative -ketoglutate (119), or with several TCA cycle metabolites 
extends lifespan (103). This longevity gain in worms is thought to be mediated 
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by anaplerotic reactions (103,119). The energy sensor AMPK senses and 
modulates the metabolic and energy homeostasis changes of these long-lived 
worms, and the DAF-16/FOXO pathway is also activated by higher levels of 
TCA cycle intermediates (103).  
 
The ketogenic or glucogenic potential of ingested AAs may also affect long-
term health and ageing in rodents and humans. In mice, highly ketogenic diets 
reduce the catabolism of ketogenic AAs to prevent further ketogenesis, but do 
not alter lifespan (13). However, a modest increase in the intake of ketogenic 
compounds may be beneficial for mouse lifespan. Increasing the intake of the 
ketogenic AA leucine contributes to the mouse lifespan extension by BCAA 
supplementation (113), while in a mouse cancer model two different ketogenic 
compounds, butanediol and ketone ester, significantly increased survival 
independently of DR (114). In humans, ketogenic or leucine-supplemented 
diets may decrease food intake, adiposity, insulin resistance, sarcopenia, and 
cognitive deterioration with age (115-118). However, the TCA cycle is 
amphibolic, i.e. it is both anaplerotic and cataplerotic. This makes it difficult to 
quantify its bioenergetic modulations upon intake of different AAs. Therefore 
ketogenesis, TCA metabolite levels, and energy flux are coordinated by 
different AA ingestions to induce health and longevity gains across species. 
However, more investigations are needed to further elucidate how AA 
catabolism impacts on health and ageing through such modulations. 
 
X. Health biomarkers of specific AA-imbalances 
The AA profile of a dietary protein is generally the primary determinant of the 
protein’s nutritional value. Several studies have identified effects of different 
dietary proteins with distinct AA profiles upon health and ageing. Soy and 
whey proteins improve a range of health markers and longevity, including 
increased insulin sensitivity and reduced adiposity (Table 1). In contrast, milk 
or casein proteins increase circulating IGF-I, insulin, and satiety hormones 
compared to other protein sources, and such chronic IIS over-stimulation can 
be detrimental for ageing (Table 1). The molecular mechanisms mediating the 
effects of such different protein sources implicate their AA contents. Soy 
(Figure 5a) and whey (Figure 5b) proteins are low in methionine and 
tryptophan content (1,121), while casein has a higher methionine content than 
soy protein (Figure 5c). Tryptophan (122) and methionine (13) promote 
growth hormone (GH) secretion, so diets with lower levels of these AAs 
decrease IGF-I, thereby promoting long-term health (121). Whey protein is 
also high in the BCAAs leucine and isoleucine (Figure 5b), which may explain 
its growth-promoting and appetite-suppressing effects in animals (112), and 
its prevention of muscle loss in older humans (117). Egg protein is a high-
quality protein for growth (112), but is not necessarily optimal for long-term 
health as it causes high postprandial levels of circulating glucose 
accompanied by a low appetite suppression effect (111). Therefore specific 
protein sources with distinct AA profiles can down-regulate IIS and increase 
healthspan and longevity.  
 
Other endocrine modulations involve thyroid hormones, with soy protein 
lowering parathyroid (PTH) hormone secretion (Table 1), which in humans is 
linked to BMI and mortality, at least under some pathological conditions. 
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Along with growth hormones, secretion of thyroid hormones is also reduced 
by DR (6) and tryptophan restriction (14). In mice, increased plasma levels of 
BCAAs are associated with decreased lifespan (3), but high dietary BCAAs 
have also extended lifespan presumably through different protective 
mechanisms (113) that require more detailed investigation. In humans, 
increased plasma BCAAs are linked to insulin resistance and type 2 diabetes 
(123).  
 
Fish protein is also linked to human health benefits, including increased 
insulin sensitivity and reduced circulating low-density lipoproteins (Table 1) 
(22-23). A comparison of the AA content in >10 fish species shows that the 
two most limiting AAs in fish are tryptophan and methionine (Figure 5d), with 
cysteine as the most limiting non-EAA. Some long-lived human populations, 
like Okinawans, Sardinians, or Ikarians (124) are located in areas were fish is 
a predominant protein source (125-126). Thus it is tempting to draw a link 
between the reduced sulphur AAs and tryptophan and the insulin sensitivity 
and lifespan-extension observed in these populations.  
 
In humans, several cohort studies show that high intakes of animal protein, 
which is typically methionine-rich, are positively associated with chronic and 
age-related disease, and this association is abolished when the dietary 
protein source is plant-based (11). However, the age of an individual also 
determines the health response to the ingested protein (11), as discussed 
below. 
 
The bioenergetics of different AA sources may also contribute to health 
effects. The metabolic efficiency of different dietary proteins integrates their 
AA composition and the energy used in the catabolism of each AA to produce 
one ATP molecule (120). A comparison of the metabolic efficiency of different 
dietary proteins shows that proteins linked to beneficial effects for healthspan 
and lifespan in animals and humans (Table 1) tend to have an essential AA 
profile that has a higher metabolic efficiency (Figure 6a). The calculated % 
energy efficiency is lower for lactalbumin, egg, and casein, and higher for soy 
and fish proteins. Therefore it is possible, although not yet established, that a 
link between metabolic efficiency of AA catabolic reactions and health exists.  
 
Interestingly, in the two recent DR primate studies, the WNPRC diet had 
higher contents of tryptophan and BCAAs (lactalbumin) than the NIA diet 
(fish-soybean-wheat-corn-alfalfa) (Figure 6b). Milk and dairy proteins such as 
lactalbumin can induce TOR activation and insulin resistance in humans 
(23,122). Thus, AA intake differences between the two studies could 
contribute to differences in mortality and cancer incidence, as a higher intake 
of BCAAs and tryptophan could have lead to a chronically higher TOR/IIS 
stimulation (5).  
 
In conclusion, a number of observations suggests an important role of dietary 
AA intake upon health and ageing in humans.  
 
4. Optimal amino acid intake 
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I. Variation in requirement for amino acids. 
The AA needs of individuals, populations, and species, are influenced 
dynamically by internal state and environmental factors. The main sources 
leading to variation in AA requirements are discussed here. 
 
Although not much studied beyond inborn errors of metabolism, genetic 
background across and within species impacts greatly on the response to AA 
consumption. Inter-strain variability for the requirement of some AAs (e.g. 
glycine) has been shown to be significant in Drosophila (147). In rodents and 
humans, genetic background profoundly affects body size, AA requirements, 
and food intake (4,27). Wild strains of worms and flies live longer upon DR 
(127), and mice of different strains respond diversely to a single DR regime 
(128). The genetic background may also contribute to differences in the DR 
response observed in the recent primate studies (5). Single DR regimes do 
not indicate the response of a mouse strain across different restriction levels 
(26), but do suggest that genetic constitution profoundly impacts on the 
response to reduced intake of nutrients including AAs. Some recent 
approaches assess single nucleotide polymorphisms (SNPs) to identify 
specific genes and to explain how genetic variation in inbred mouse 
populations determines traits of interest (129). Similar approaches could be 
employed to evaluate the role of genetic determinants in the DR response, 
both in rodents and in humans. Such information will inform our understanding 
of how natural genetic variation predisposes the DR response both in model 
organisms and in humans, and even aid the design of individualized 
nutritional interventions. 
 
All growing or reproducing mammals, including humans, have higher AA 
requirements than adults (27,30). Consequently young children are more 
susceptible to protein malnutrition and related diseases such as Kwashiorkor. 
For laboratory animals there is a clear distinction between diets optimized for 
breeding or growth stages versus diets optimized for long-term maintenance 
(27). Adjusting the dietary protein supply to match AA requirements with age 
promotes health and longevity. Providing high dietary protein to young 
animals and lower to mature ones extends lifespan in rats (9,130) and mice 
(6). In rodents, protein absorption reduces with age as older rats show a 
decreased ability to digest proteins and AAs (131). Moreover, mature rodents 
fail to show some of the adverse effects of ingesting AA-imbalanced diets (24-
25). Accordingly, BCAA stimulation of the IIS/TOR pathways is greater in 
younger, not older, animals (78). Therefore it is not surprising that early onset 
DR extends rodent lifespan significantly (132), but late onset DR is less 
effective (6). The protein source during early life also impacts on health during 
ageing. Although milk protein can chronically over-stimulate IIS and contribute 
to insulin resistance (Table 1), restriction of milk-protein during weaning only 
can significantly increase mouse lifespan (133). Requirements for AAs may 
also change qualitatively as an animal physically matures. Some evidence in 
mice suggest subtle changes in the body’s AA composition with development 
(134). In humans, a low protein intake appears to benefit groups of 50-65 
years of age, but may be detrimental when applied to older ages (11). 
Therefore, it is clear that age and life stage can affect both the requirement for 
AAs, and the response to AA intakes. 
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The EAA requirements of individual cells or tissues can vary depending on 
tissue-specific AA metabolism. For example, enterocytes secrete threonine-
rich proteins, so require a higher threonine intake than other cells (47,55). 
Hepatocytes require high levels of methionine to serve many transulfation, 
transmethylation, and folate metabolism reactions (55). The type and 
abundance of AA transporters also determines which AAs enter readily into 
which cells. These aspects require further study in conjunction with more 
systematic analysis of tissue-specific usage of individual AAs. 
 
In humans, gender defines AA requirements as males require more AAs than 
non-pregnant females, which reflects body size differences to an extent 
(4,30). Beyond inborn errors of metabolism, the maintenance of health 
requires adequate AA supply, as multiple immunological processes depend 
on AAs, and an imbalanced AA intake can suppress the immune system (20). 
Indeed, the efficiency of the immune response declines and the susceptibility 
to infections increases upon low AA intake (4). Thus, it is possible that 
infectious or disease conditions that increase the function of immunological 
processes may raise dietary AA requirements (20). In the future, more work is 
required to understand how specific disease states increase the requirement 
for specific AAs. 
 
In addition, healthy physical activity increases the metabolic rate and 
promotes protein degradation, AA oxidation, and depression of protein 
synthesis in humans, thereby increasing AA requirements (4). The metabolic 
rate of individuals can also be modulated by environmental conditions, as 
lower temperatures can increase the metabolic rate in endothermic animals 
(4). Similarly, seasonal increases in day cycle duration can promote physical 
activity, thereby increasing the metabolic rate particularly at younger ages (4). 
Such increases in metabolic rate also translate in increases in AA 
requirements.  
 
In summary, numerous findings from different branches of nutritional research 
clearly indicate that both environmental and internal state factors must be 
considered when estimating of AA requirements. 
 
 
5. Conclusions 
 
Identifying beneficial AA intakes can lead to improvements in human nutrition. 
In human populations, health benefits for older age groups mirror most 
mortality gains, and late life dietary interventions based on AA intake are 
beneficial (11). As AA intakes are critical to the DR response, dietary AAs 
provide a powerful intervention strategy for human health. Indeed, recent 
evidence shows that a fasting mimicking diet based on a limited plant-based 
AA intake benefits human health (17). Such dietary manipulations comprise a 
drug-free way of intervening towards healthy ageing. Moreover, nutritional 
efficiency can have diverse applications within our societies, as it can help to 
end starvation, to devise tools against obesity and disease, to enhance 
produce yield in the food industry, and to assist patients in numerous clinical 
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applications including cancer.  
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Figure 1 
 
The metabolic fate of ingested amino acids. Modified from Berg et al. 2007 
(144) 
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Figure 2 
 
GCN2-dependent sensing of AA limitations. Extracellular amino acids (AAs) 
can activate their cognate tRNA, which is now available for ribosomal protein 
synthesis (LS=large subunit, SS=small subunit). In contrast, uncharged 
tRNAs bind to and activate by phosphorylation GCN2, which in turn 
phosphorylates eIF2. This activates the eIF2 complex to stimulate ATF4, 
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which induces FGF21 to trigger the amino acid response (AAR), which inhibits 
anabolic processes, and promotes catabolism (see main text). 
 
 
 
 
 
 
Figure 3 
 
TOR-dependent sensing of AAs. Intracellular AAs activate TORC1 through 
multiple TOR-associated factors (see main text for details). GAP - GTPase-
activating protein; GEF - guanine nucleotide exchange factor (GEF) 
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Figure 4 
 
Sensing of dietary proteins and AAs along the gastrointestinal (GI) tract. 
Ingested AAs activate transceptors (e.g. GPCRs) that relay hormonal and 
neural signals of satiety to the brain. Protein or amino acid intake can also 
stimulate the secretion of a range of appetite suppressors including PYY, 
CCK, and GLP-1 (see main text). Such hormonal signals are targeted to the 
hypothalamus, which regulates a range of systemic and metabolic processes 
that are associated with homeostasis and health during ageing. 
 
 
 
 
 28 
 
 
 
 
 
 
 
 
Table 1 
 
List of findings relating dietary protein sources to healthspan and lifespan, 
including effects upon the IIS and TOR pathways, and on circulating 
metabolites linked to health-related parameters.  
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Figure 5 
 
A) Four published soy EAA profiles show considerable batch-to-batch 
variability and low levels of tryptophan and methionine. Molar proportions are 
shown. 
 
B) The essential AA proportional representation in three published whey 
profiles. Five of the essential AAs, including methionine and tryptophan, are 
particularly low, but leucine is higher than in soy, fish, or casein proteins. 
 
C) Six bovine casein EAA profiles indicate differences between casein 
sources within the same species (Bos taurus), low contents of tryptophan, and 
higher levels of methionine compared to whey or soy proteins. 
D) An analysis of the AA profile of ten teleost fish species indicates 
limitations in tryptophan, histidine, and methionine. However, due to the 
severe limitation in cysteine, the limitation of methionine likely surpasses that 
of histidine, making methionine the second most limiting AA. Also, a lower 
leucine level is seen compared to soy, whey, or casein proteins. 
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Figure 6 
 
A) The calculated % energy expenditure for the production of one ATP 
molecule based on non-integral P/O ratios (Milgen 2002), shown for the 
essential AA composition of five common types of dietary protein: lactalbumin, 
egg, casein, soy, and fish. Differences are due to the range of carbon chain 
and cofactors that result from essential AA catabolism. Some protein sources 
associated with health benefits (Table 1) appear to have a proportionally 
higher metabolic efficiency than proteins associated with detrimental effects. 
 
 
B) Comparison of the mean EAA content (from published data) of the six 
protein sources used in the two primate studies (see main text for discussion). 
Lactalbumin has a particularly high content in tryptophan and isoleucine, as 
well as leucine. 
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Summary points list (8) 
 
1. Even with adequate intake of macronutrients, the protein and amino 
acid content of the diet are critical for health during ageing 
 
2. An imbalanced supply of amino acids occurs when the requirement for 
dietary amino acids, usually determined by their effects on anabolic 
traits, is not matched by their intake 
 
3. This requirement is affected by multiple factors including genetic 
diversity, gender, age, and health status 
 
4. Amino acid absorption and availability is determined by the gut 
microbiota, the amino acid’s identity, and first pass metabolism 
 
5. Ingested and systemically available AAs are sensed by various 
mechanisms, involving TOR, GCN2, GPCRs, and other sensors 
 
6. Excess intakes of amino acids can over-stimulate growth signaling, 
which can be chronically detrimental and decrease longevity 
 
7. Limiting or imbalanced intakes of amino acids can down-regulate 
growth signaling, inducing a maintenance mode 
 
8. Experimental animal models can inform human nutrition, increasing our 
understanding of how AA intakes affect human health and ageing 
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Abbreviations-Acronyms 
 
1. DR – dietary restriction 
2. AA – amino acid 
3. EAA – essential AA 
4. NEAA – non EAA 
5. BCAA – branched-chain AA 
6. IIS – insulin and insulin-like growth factor 1 (IGF1) signalling 
7. mTOR – mammalian target of rapamycin 
8. SB – splanchnic bed 
9. TCA cycle - tricarboxylic acid cycle 
10. TAGs – triacylglycerides 
11. ATF – activating transcription factor 
12. GCN2 - general control nonderepressible 2 
13. AMPK - denosine monophosphate-activated protein kinase 
14. AAR – amino acid response 
15. ASNS – asparagine synthetase 
16. CNS - central nervous system 
17. GAP activity - GTPase-activating protein (GAP) activity 
18. GEF activity - guanine nucleotide exchange factor (GEF) activity 
19. GPCR - G-protein-coupled receptor 
20. GLP-1 - Glucagon-like peptide-1 
21. PYY - peptide YY 
22. CCK – Cholecystokinin 
23. FOXO - transcription factor Forkhead box O  
24. BMI – body mass index 
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Key terms – definitions (9) 
(<20 words / definition) 
 
1. Macronutrient ratio: the relative proportions of protein, carbohydrates, 
and fats in a diet 
 
2. Amino acid bioavailabilty: the fraction of an absorbed amino acid that 
reaches systemic circulation 
 
3. Dietary amino acid imbalance: when the intake of amino acids does not 
match the AA requirements of an organism for a specific trait 
 
4. Dietary amino acid limitation: when an AA intake is below the 
organism’s requirement for a given trait 
 
5. Dietary amino acid excess: when the AA intake exceeds the 
organism’s requirement for a given trait 
 
6. Nutrient sensing: a collection of systemic, neural and cell autonomous 
signals elicited in response to nutrient and/or energy intake 
 
7. Transceptors: transmembane transporters of nutrients, including amino 
acids, that can also act as receptors, therefore having signaling 
capacity 
 
8. Energy homeostasis: the set of balancing adjustments aiming at 
metabolic equilibrium 
 
9. Amino acid bioavailabilty: the fraction of an ingested amino acid that 
can be metabolized 
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Future issues list (8) 
 
1. A full characterization of the AA transporters across tissues, e.g. along 
the brain-blood-barrier, to further inform how the CNS senses each AA 
limitation 
 
2. Further elucidation of the interactions of transceptors and intracellular 
AA sensors across tissues 
 
3. Full description of the interactions between systemic (e.g. hormonal) 
and local (e.g. GCN2, TOR) responses to ingested AAs 
 
4. Characterization of the metabolic role of circulating AAs, and of the 
energy efficiency and metabolic flux of different AA sources 
 
5. Further clarification of TOR activation by specific-AAs to include all 
essential and non-essential AAs 
 
6. Detailed quantification of uncharged tRNA abundance and consequent 
GCN2 activation, both with free AA diets and protein diets 
 
7. Elucidation of TOR-independent and GCN2-independent sensing of 
AAs 
 
8. Clarification of the role of IIS and TOR over-stimulation in health 
deterioration and age-related pathology 
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Annotated references 
(<15 words per annotation) 
 
1. World Health Organ. 2007. Protein and amino acid requirements in 
human nutrition. Geneva: United Nations University 
 
Lists methodological and biological factors affecting AA requirements; 
provides AA requirements across ages and genders 
 
 
2. Fontana, L. & Partridge, L. Promoting Health and Longevity 
through Diet: From Model Organisms to Humans. Cell 161, 106–
118 (2015). 
 
Account of the effects of dietary interventions upon health and lifespan 
across species 
 
3. Westerterp-Plantenga, M.S., Nieuwenhuizen, A., Tome, D., 
Soenen, S. & Westerterp, K.R. Dietary protein, weight loss, and 
weight maintenance. Annu. Rev. Nutr. 29, 21–41 (2009). 
 
Discusses the role of protein intake in the modulation of metabolism and 
obesity in humans 
 
4. Harper, A.E., Benevenga, N.J. & Wohlhueter, R.M. Effects of 
ingestion of disproportionate amounts of amino acids. Physiol Rev 
50, 428–558 (1970). 
 
Review of how imbalanced AA intakes can affect health and physiology in 
rodents 
 
5. Lupton, J.R. et al. Dietary Reference Intakes for Energy, 
Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and 
Amino Acids. 1331 (The National Academies Press: Washington 
D.C., 2001). 
 
Review of methodological and biological factors affecting human AA 
requirements 
 
6. Gietzen, D.W., Hao, S. & Anthony, T.G. Mechanisms of Food 
Intake Repression in Indispensable Amino Acid Deficiency. Annu. 
Rev. Nutr. 27, 63–78 (2007). 
 
Report on GCN2-mediated molecular responses to AA limitations 
 
7. Chaveroux, C. et al. Molecular mechanisms involved in the 
adaptation to amino acid limitation in mammals. Biochimie 92, 
736–745 (2010). 
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Revision of transcriptional and translational adaptations to limiting AAs 
 
8. Benevenga, N.J. et al. Nutrient Requirements of Laboratory 
Animals. 175 (National Academy Press: Washington, D.C., 1995). 
 
Official AA recommendations for laboratory animals, based on thorough 
review of literature and empirical data 
 
 
 
